High-performance Liquid Chromatography Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Consumables & Accessories, Software); By Application; By End-Use; By Region; Segment Forecast, 2022 - 2030
Description
The global High-performance Liquid Chromatography market size is expected to reach USD 8.92 billion by 2034, according to a new study by Polaris Market Research. The report “High-performance Liquid Chromatography Market Share, Size, Trends, Industry Analysis Report, By Product; By Application; By End-Use; By Region; Segment Forecast, 2025- 2034” gives a detailed insight into current market dynamics and provides an analysis of future market growth.
The major factors accelerating the markets are the high prevalence of acute and chronic diseases, the growing number of applications for HPLC, and the rising requirement for preclinical and clinical trials for efficient drug discovery processes all contribute to the market's revenue growth. In addition, the increasing use of liquid chromatography instruments in pharmaceuticals, agriculture, and forensics is expected to propel the high-performance liquid chromatography market forward.
Government intervention in the fields of food safety and environmental regulation, a growing emphasis on accurate diagnostics, and an increasing acceptance of chromatographic techniques as a standard procedure for testing the validity and specificity of drug components are all expected to contribute to market growth. Furtherly, expanding pharmaceutical R&D activity also boost the market over the forecast period.
Additionally, the COVID-19 pandemic has speed up the usage of HPLC systems for the development of new therapies, vaccinations, and disease diagnosis techniques. Research and development activities have shifted more toward the SARS-CoV-2 virus and the identification of potential therapeutic therapy candidates during the outbreak. In drug formulation labs, HPLC is a key technology used for the identification and analysis of specific components in drug mixtures.
High-performance Liquid Chromatography Market Report Highlights
Due to the availability of advanced detectors and the growing dominance of integrated HPLC systems, the instrument market sector had the biggest revenue share in 2024. Additionally, as research and development in the pharmaceutical, biotech, food, and agricultural industries increases, the market will expand.
The clinical research application held the greatest revenue share owing to the expandable clinical trial activities, a surge in biopharmaceutical research and development, and growing need for high throughput analytical techniques.
The pharmaceutical and biotechnology companies are expected to grow at good pace due to the similarity of HPLC with mass spectrometry, which strengthen the detection scope and selectivity of the technique. This increases the growth of biopharmaceutical applications and is likely boost the market.
The North American region is expected to expand due to the high spending on research and development, increasing demand for clinical diagnostic applications, and the presence of major key players in this region. Several US government research facilities also use HPLC methods to investigate particular drug mixture components or associated components.
Major players operating in the industry include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Gilson, Inc., Merck KGaA, PerkinElmer, Inc, Sartorius AG, Shimadzu Corporation, Thermo Fisher Scientific, Inc., Tosoh Bioscience GmbH, Thermo Fisher Scientific, Inc., Waters Corporation
Polaris Market Research has segmented the High-performance Liquid Chromatography market report based on product, application, end-use, and region:
High-performance Liquid Chromatography, Product Outlook (Revenue - USD Billion, 2020-2034)
Instruments
HPLC Systems
Pumps
Detectors
Others
Consumables& Accessories
Columns
Reverse-phase HPLC Columns
Normal-phase HPLC Columns
Ion Exchange HPLC Columns
Size Exclusion HPLC Columns
Other HPLC Columns
Filters
Vials
Tubes
Others
Software
High-performance Liquid Chromatography, Application Outlook (Revenue - USD Billion, 2020-2034)
Clinical Research Applications
Diagnostic Applications
Forensic Applications
Other Applications
High-performance Liquid Chromatography End-Use Outlook (Revenue - USD Billion, 2020-2034)
Pharmaceutical & Biotechnology Companies
Academic & Research Institutions
Others
High-performance Liquid Chromatography, Regional Outlook (Revenue - USD Billion, 2020-2034)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
The major factors accelerating the markets are the high prevalence of acute and chronic diseases, the growing number of applications for HPLC, and the rising requirement for preclinical and clinical trials for efficient drug discovery processes all contribute to the market's revenue growth. In addition, the increasing use of liquid chromatography instruments in pharmaceuticals, agriculture, and forensics is expected to propel the high-performance liquid chromatography market forward.
Government intervention in the fields of food safety and environmental regulation, a growing emphasis on accurate diagnostics, and an increasing acceptance of chromatographic techniques as a standard procedure for testing the validity and specificity of drug components are all expected to contribute to market growth. Furtherly, expanding pharmaceutical R&D activity also boost the market over the forecast period.
Additionally, the COVID-19 pandemic has speed up the usage of HPLC systems for the development of new therapies, vaccinations, and disease diagnosis techniques. Research and development activities have shifted more toward the SARS-CoV-2 virus and the identification of potential therapeutic therapy candidates during the outbreak. In drug formulation labs, HPLC is a key technology used for the identification and analysis of specific components in drug mixtures.
High-performance Liquid Chromatography Market Report Highlights
Due to the availability of advanced detectors and the growing dominance of integrated HPLC systems, the instrument market sector had the biggest revenue share in 2024. Additionally, as research and development in the pharmaceutical, biotech, food, and agricultural industries increases, the market will expand.
The clinical research application held the greatest revenue share owing to the expandable clinical trial activities, a surge in biopharmaceutical research and development, and growing need for high throughput analytical techniques.
The pharmaceutical and biotechnology companies are expected to grow at good pace due to the similarity of HPLC with mass spectrometry, which strengthen the detection scope and selectivity of the technique. This increases the growth of biopharmaceutical applications and is likely boost the market.
The North American region is expected to expand due to the high spending on research and development, increasing demand for clinical diagnostic applications, and the presence of major key players in this region. Several US government research facilities also use HPLC methods to investigate particular drug mixture components or associated components.
Major players operating in the industry include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Gilson, Inc., Merck KGaA, PerkinElmer, Inc, Sartorius AG, Shimadzu Corporation, Thermo Fisher Scientific, Inc., Tosoh Bioscience GmbH, Thermo Fisher Scientific, Inc., Waters Corporation
Polaris Market Research has segmented the High-performance Liquid Chromatography market report based on product, application, end-use, and region:
High-performance Liquid Chromatography, Product Outlook (Revenue - USD Billion, 2020-2034)
Instruments
HPLC Systems
Pumps
Detectors
Others
Consumables& Accessories
Columns
Reverse-phase HPLC Columns
Normal-phase HPLC Columns
Ion Exchange HPLC Columns
Size Exclusion HPLC Columns
Other HPLC Columns
Filters
Vials
Tubes
Others
Software
High-performance Liquid Chromatography, Application Outlook (Revenue - USD Billion, 2020-2034)
Clinical Research Applications
Diagnostic Applications
Forensic Applications
Other Applications
High-performance Liquid Chromatography End-Use Outlook (Revenue - USD Billion, 2020-2034)
Pharmaceutical & Biotechnology Companies
Academic & Research Institutions
Others
High-performance Liquid Chromatography, Regional Outlook (Revenue - USD Billion, 2020-2034)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
117 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
- 4. U.S. Medical Plastics Market Insights
- 4.1. U.S. Medical Plastics Market – Market Snapshot
- 4.2. U.S. Medical Plastics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Geriatric Population
- 4.2.1.2. Increasing Healthcare Spending
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Stringent Regulatory Compliance
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. U.S. Medical Plastics Market Trends
- 4.6. Value Chain Analysis
- 5. U.S. Medical Plastics Market, by Polymer Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. U.S. Medical Plastics Market, by Polymer Type, 2020-2034 (USD Billion)
- 5.3. Thermoplastics
- 5.3.1. U.S. Medical Plastics Market, by Thermoplastics, by Region, 2020-2034 (USD Billion)
- 5.3.2. Polypropylene (PP)
- 5.3.2.1. U.S. Medical Plastics Market, by Polypropylene (PP), by Region, 2020-2034 (USD Billion)
- 5.3.3. Polyvinyl Chloride (PVC)
- 5.3.3.1. U.S. Medical Plastics Market, by Polyvinyl Chloride (PVC), by Region, 2020-2034 (USD Billion)
- 5.3.4. Polyethylene (PE)
- 5.3.4.1. U.S. Medical Plastics Market, by Polyethylene (PE), by Region, 2020-2034 (USD Billion)
- 5.3.5. Polycarbonate (PC)
- 5.3.5.1. U.S. Medical Plastics Market, by Polycarbonate (PC), by Region, 2020-2034 (USD Billion)
- 5.3.6. Polyurethane
- 5.3.6.1. U.S. Medical Plastics Market, by Polyurethane, by Region, 2020-2034 (USD Billion)
- 5.3.7. Acrylonitrile Butadiene Styrene (ABS)
- 5.3.7.1. U.S. Medical Plastics Market, by Acrylonitrile Butadiene Styrene (ABS), by Region, 2020-2034 (USD Billion)
- 5.3.8. Others
- 5.3.8.1. U.S. Medical Plastics Market, by Others, by Region, 2020-2034 (USD Billion)
- 5.4. Elastomers
- 5.4.1. U.S. Medical Plastics Market, by Elastomers, by Region, 2020-2034 (USD Billion)
- 5.5. Biodegradable Polymers
- 5.5.1. U.S. Medical Plastics Market, by Biodegradable Polymers, by Region, 2020-2034 (USD Billion)
- 5.6. Others
- 5.6.1. U.S. Medical Plastics Market, by Others, by Region, 2020-2034 (USD Billion)
- 6. U.S. Medical Plastics Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. U.S. Medical Plastics Market, by Application, 2020-2034 (USD Billion)
- 6.3. Medical Instruments & Devices
- 6.3.1. U.S. Medical Plastics Market, by Medical Instruments & Devices, by Region, 2020-2034 (USD Billion)
- 6.4. Medical Disposables
- 6.4.1. U.S. Medical Plastics Market, by Medical Disposables, by Region, 2020-2034 (USD Billion)
- 6.5. Diagnostic Instruments & Tools
- 6.5.1. U.S. Medical Plastics Market, by Diagnostic Instruments & Tools, by Region, 2020-2034 (USD Billion)
- 6.6. Others
- 6.6.1. U.S. Medical Plastics Market, by Others, by Region, 2020-2034 (USD Billion)
- 7. U.S. Medical Plastics Market, by Manufacturing
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. U.S. Medical Plastics Market, by Manufacturing, 2020-2034 (USD Billion)
- 7.3. Extrusion Tubing
- 7.3.1. U.S. Medical Plastics Market, by Extrusion Tubing, by Region, 2020-2034 (USD Billion)
- 7.4. Injection Molding
- 7.4.1. U.S. Medical Plastics Market, by Injection Molding, by Region, 2020-2034 (USD Billion)
- 7.5. Compression Molding
- 7.5.1. U.S. Medical Plastics Market, by Compression Molding, by Region, 2020-2034 (USD Billion)
- 7.6. Others
- 7.6.1. U.S. Medical Plastics Market, by Others, by Region, 2020-2034 (USD Billion)
- 8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
- 9. Company Profiles
- 9.1. Arkema
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. BASF
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Celanese Corporation
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Covestro
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Dow
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. DuPont
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Eastman Chemical Company
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Ensinger
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Evonik Industries AG
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Lubrizol
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Solvay
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
